These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

460 related items for PubMed ID: 22673539

  • 1. Expression of Ki67, BCL-2, and COX-2 in canine cutaneous mast cell tumors: association with grading and prognosis.
    Vascellari M, Giantin M, Capello K, Carminato A, Morello EM, Vercelli A, Granato A, Buracco P, Dacasto M, Mutinelli F.
    Vet Pathol; 2013 Jan; 50(1):110-21. PubMed ID: 22673539
    [Abstract] [Full Text] [Related]

  • 2. Histologic grading of canine mast cell tumor: is 2 better than 3?
    Sabattini S, Scarpa F, Berlato D, Bettini G.
    Vet Pathol; 2015 Jan; 52(1):70-3. PubMed ID: 24513799
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Validation of the prognostic value of histopathological grading or c-kit mutation in canine cutaneous mast cell tumours: a retrospective cohort study.
    Takeuchi Y, Fujino Y, Watanabe M, Takahashi M, Nakagawa T, Takeuchi A, Bonkobara M, Kobayashi T, Ohno K, Uchida K, Asano K, Nishimura R, Nakayama H, Sugano S, Ohashi Y, Tsujimoto H.
    Vet J; 2013 Jun; 196(3):492-8. PubMed ID: 23384436
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparison of minichromosome maintenance protein 7, Ki67 and mitotic index in the prognosis of intermediate Patnaik grade cutaneous mast cell tumours in dogs.
    Berlato D, Murphy S, Laberke S, Rasotto R.
    Vet Comp Oncol; 2018 Dec; 16(4):535-543. PubMed ID: 29989314
    [Abstract] [Full Text] [Related]

  • 7. Comparison of 2- and 3-category histologic grading systems for predicting the presence of metastasis at the time of initial evaluation in dogs with cutaneous mast cell tumors: 386 cases (2009-2014).
    Stefanello D, Buracco P, Sabattini S, Finotello R, Giudice C, Grieco V, Iussich S, Tursi M, Scase T, Di Palma S, Bettini G, Ferrari R, Martano M, Gattino F, Marrington M, Mazzola M, Elisabetta Vasconi M, Annoni M, Marconato L.
    J Am Vet Med Assoc; 2015 Apr 01; 246(7):765-9. PubMed ID: 25794126
    [Abstract] [Full Text] [Related]

  • 8. An immunohistochemical study of vitamin D receptor expression in canine cutaneous mast cell tumours.
    Russell DS, Rassnick KM, Erb HN, Vaughan MM, McDonough SP.
    J Comp Pathol; 2010 Apr 01; 143(2-3):223-6. PubMed ID: 20334872
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The use of KIT and tryptase expression patterns as prognostic tools for canine cutaneous mast cell tumors.
    Kiupel M, Webster JD, Kaneene JB, Miller R, Yuzbasiyan-Gurkan V.
    Vet Pathol; 2004 Jul 01; 41(4):371-7. PubMed ID: 15232137
    [Abstract] [Full Text] [Related]

  • 11. All subunits of the interleukin-2 receptor are expressed by canine cutaneous mast cell tumours.
    Meyer A, Gruber AD, Klopfleisch R.
    J Comp Pathol; 2013 Jul 01; 149(1):19-29. PubMed ID: 23276382
    [Abstract] [Full Text] [Related]

  • 12. Canine mast cell tumors: correlation of apoptosis and proliferation markers with prognosis.
    Scase TJ, Edwards D, Miller J, Henley W, Smith K, Blunden A, Murphy S.
    J Vet Intern Med; 2006 Jul 01; 20(1):151-8. PubMed ID: 16496935
    [Abstract] [Full Text] [Related]

  • 13. c-KIT messenger RNA and protein expression and mutations in canine cutaneous mast cell tumors: correlations with post-surgical prognosis.
    Giantin M, Vascellari M, Morello EM, Capello K, Vercelli A, Granato A, Lopparelli RM, Nassuato C, Carminato A, Martano M, Mutinelli F, Dacasto M.
    J Vet Diagn Invest; 2012 Jan 01; 24(1):116-26. PubMed ID: 22362941
    [Abstract] [Full Text] [Related]

  • 14. Expression of Fibroblast Activating Protein and Correlation with Histological Grade, Mitotic Index and Ki67 Expression in Canine Mast Cell Tumours.
    Giuliano A, Dos Santos Horta R, Constantino-Casas F, Hoather T, Dobson J.
    J Comp Pathol; 2017 Jan 01; 156(1):14-20. PubMed ID: 27889201
    [Abstract] [Full Text] [Related]

  • 15. Immunohistochemical characterization of feline mast cell tumors.
    Mallett CL, Northrup NC, Saba CF, Rodriguez CO, Rassnick KM, Gieger TL, Childress MO, Howerth EW.
    Vet Pathol; 2013 Jan 01; 50(1):106-9. PubMed ID: 22492208
    [Abstract] [Full Text] [Related]

  • 16. The value of immunohistochemical expression of BAX in formulating a prognosis for canine cutaneous mast cell tumours.
    Strefezzi Rde F, Kleeb SR, Xavier JG, Fukumasu H, Catão-Dias JL.
    J Comp Pathol; 2012 May 01; 146(4):314-9. PubMed ID: 21899858
    [Abstract] [Full Text] [Related]

  • 17. Differences in the proteome of high-grade versus low-grade canine cutaneous mast cell tumours.
    Schlieben P, Meyer A, Weise C, Bondzio A, Einspanier R, Gruber AD, Klopfleisch R.
    Vet J; 2012 Nov 01; 194(2):210-4. PubMed ID: 22578690
    [Abstract] [Full Text] [Related]

  • 18. Variation among pathologists in histologic grading of canine cutaneous mast cell tumors.
    Northrup NC, Harmon BG, Gieger TL, Brown CA, Carmichael KP, Garcia A, Latimer KS, Munday JS, Rakich PM, Richey LJ, Stedman NL, Cheng AL, Howerth EW.
    J Vet Diagn Invest; 2005 May 01; 17(3):245-8. PubMed ID: 15945380
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of Ki67, Bax, Bcl-2 and KIT in canine cutaneous mast cell tumours and their relationship with histopathology and prognosis.
    Aytemiz Danyer I, Gürel A.
    Acta Vet Hung; 2024 Jan 09; 71(3-4):183-192. PubMed ID: 38112689
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of a two-centimeter lateral surgical margin for excision of grade I and grade II cutaneous mast cell tumors in dogs.
    Fulcher RP, Ludwig LL, Bergman PJ, Newman SJ, Simpson AM, Patnaik AK.
    J Am Vet Med Assoc; 2006 Jan 15; 228(2):210-5. PubMed ID: 16426187
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.